Waters/$WAT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Waters
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.
Ticker
$WAT
Sector
Primary listing
NYSE
Industry
Life Sciences Tools and Services
Headquarters
Employees
7,600
Website
Waters Metrics
BasicAdvanced
$17B
26.09
$11.02
1.14
-
Price and volume
Market cap
$17B
Beta
1.14
52-week high
$423.56
52-week low
$279.62
Average daily volume
799K
Financial strength
Current ratio
1.811
Quick ratio
1.141
Long term debt to equity
74.232
Total debt to equity
78.582
Interest coverage (TTM)
10.78%
Profitability
EBITDA (TTM)
1,021.882
Gross margin (TTM)
59.27%
Net profit margin (TTM)
22.02%
Operating margin (TTM)
28.33%
Effective tax rate (TTM)
16.08%
Revenue per employee (TTM)
$390,000
Management effectiveness
Return on assets (TTM)
11.39%
Return on equity (TTM)
40.82%
Valuation
Price to earnings (TTM)
26.095
Price to revenue (TTM)
5.722
Price to book
8.72
Price to tangible book (TTM)
168.3
Price to free cash flow (TTM)
27.567
Free cash flow yield (TTM)
3.63%
Free cash flow per share (TTM)
1,042.76%
Growth
Revenue change (TTM)
2.57%
Earnings per share change (TTM)
8.23%
3-year revenue growth (CAGR)
1.32%
10-year revenue growth (CAGR)
3.98%
3-year earnings per share growth (CAGR)
-1.22%
10-year earnings per share growth (CAGR)
7.37%
What the Analysts think about Waters
Analyst ratings (Buy, Hold, Sell) for Waters stock.
Bulls say / Bears say
Waters Corporation reported fourth-quarter 2023 sales of $819 million, surpassing Wall Street estimates due to strong demand for its drug development services. (reuters.com)
The company's gross margin expanded by 170 basis points, and adjusted operating margin increased by 120 basis points in Q4 2023, indicating improved operational efficiency. (prnewswire.com)
Analysts have a 'Buy' consensus rating for WAT stock, with a 12-month price target of $385.27, suggesting a potential upside of approximately 10%. (stockanalysis.com)
In Q4 2023, Waters Corporation's sales declined by 4.5% as reported and 8% in organic constant currency, reflecting challenges in maintaining revenue growth. (prnewswire.com)
The company's total debt-to-equity ratio stands at 148.17%, indicating a high level of leverage that could pose financial risks. (finance.yahoo.com)
Waters Corporation's stock is trading at a price-to-earnings (P/E) ratio of 34.41, which may be considered high compared to industry peers, potentially limiting future stock appreciation. (google.com)
Data summarised monthly by Lightyear AI. Last updated on 12 Jul 2025.
Waters Financial Performance
Revenues and expenses
Waters Earnings Performance
Company profitability
Waters News
AllArticlesVideos
WATERS CORPORATION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Waters Corporation - WAT
Business Wire·7 days ago
Top Stock Movers Now: Autodesk, Fortinet, Waters, and More
Investopedia·1 week ago
Waters and BD Biosciences & Diagnostic Solutions announce $17.5B merger
Proactive Investors·1 week ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Waters stock?
Waters (WAT) has a market cap of $17B as of July 23, 2025.
What is the P/E ratio for Waters stock?
The price to earnings (P/E) ratio for Waters (WAT) stock is 26.09 as of July 23, 2025.
Does Waters stock pay dividends?
No, Waters (WAT) stock does not pay dividends to its shareholders as of July 23, 2025.
When is the next Waters dividend payment date?
Waters (WAT) stock does not pay dividends to its shareholders.
What is the beta indicator for Waters?
Waters (WAT) has a beta rating of 1.14. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.